BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9886437)

  • 1. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones.
    von Greyerz S; Zanni MP; Frutig K; Schnyder B; Burkhart C; Pichler WJ
    J Immunol; 1999 Jan; 162(1):595-602. PubMed ID: 9886437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity.
    Depta JP; Altznauer F; Gamerdinger K; Burkhart C; Weltzien HU; Pichler WJ
    J Allergy Clin Immunol; 2004 Mar; 113(3):519-27. PubMed ID: 15007356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
    Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.
    Schnyder B; Mauri-Hellweg D; Zanni M; Bettens F; Pichler WJ
    J Clin Invest; 1997 Jul; 100(1):136-41. PubMed ID: 9202065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.
    Zanni MP; von Greyerz S; Schnyder B; Brander KA; Frutig K; Hari Y; Valitutti S; Pichler WJ
    J Clin Invest; 1998 Oct; 102(8):1591-8. PubMed ID: 9788973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
    Schmid DA; Depta JP; Lüthi M; Pichler WJ
    Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA; Depta JP; Pichler WJ
    Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis.
    Werfel T; Hentschel M; Kapp A; Renz H
    J Immunol; 1997 Mar; 158(5):2500-5. PubMed ID: 9037002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
    J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific CD4+ effector T cells: analysis of factors regulating clonal expansion and cytokine production: clonal expansion and cytokine production by CD4+ effector T cells.
    Ohnuki K; Watanabe Y; Takahashi Y; Kobayashi S; Watanabe S; Ogawa S; Kotani M; Kozono H; Tanabe K; Abe R
    Biochem Biophys Res Commun; 2009 Mar; 380(4):742-7. PubMed ID: 19338745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals.
    Engler OB; Strasser I; Naisbitt DJ; Cerny A; Pichler WJ
    Toxicology; 2004 Apr; 197(1):47-56. PubMed ID: 15003333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.
    Milner JD; Kent SC; Ashley TA; Wilson SB; Strominger JL; Hafler DA
    J Immunol; 1999 Sep; 163(5):2522-9. PubMed ID: 10452989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity.
    Wu Y; Farrell J; Pirmohamed M; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2007 Apr; 119(4):973-81. PubMed ID: 17320939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition.
    Hausmann S; Martin M; Gauthier L; Wucherpfennig KW
    J Immunol; 1999 Jan; 162(1):338-44. PubMed ID: 9886404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
    Hudrisier D; Kessler B; Valitutti S; Horvath C; Cerottini JC; Luescher IF
    J Immunol; 1998 Jul; 161(2):553-62. PubMed ID: 9670927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue.
    Kim BS; Bahk YY; Kang HK; Yauch RL; Kang JA; Park MJ; Ponzio NM
    J Immunol; 1999 Jun; 162(12):7049-57. PubMed ID: 10358147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals.
    Schnyder B; Burkhart C; Schnyder-Frutig K; von Greyerz S; Naisbitt DJ; Pirmohamed M; Park BK; Pichler WJ
    J Immunol; 2000 Jun; 164(12):6647-54. PubMed ID: 10843725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.